Cystic Fibrosis
📧 Sign up to get email alerts when something new happens for Cystic Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: The Effect of Telerehabilitation on Functional Capacity, Oxidative Stress and Respiratory Parameters in Cystic Fibrosis [NA]
A completed clinical trial from Hacettepe University evaluating whether telerehabilitation improves functional capacity, oxidative stress, a…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Saline Hypertonic in Preschoolers + CT [Phase 2, Phase 3]
Phase 2/3 clinical trial update for saline hypertonic treatment in preschoolers with Cystic Fibrosis; study completed.
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: Pharmacokinetics of Omadacycline in Cystic Fibrosis [Phase 4]
A Phase 4 clinical trial reports pharmacokinetics data for omadacycline in patients with cystic fibrosis.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis [Phase 4]
Phase 4 clinical trial evaluating vitamin D and prebiotics for intestinal health in cystic fibrosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis [Phase 1, Phase 2]
Phase 1/2 trial evaluating inhaled AP-PA02 for safety and tolerability in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy [Phase 3]
Phase 3 study assessing long-term safety and efficacy of VX-445 combination therapy in cystic fibrosis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: Lung Transplant READY Pilot Study [NA]
A completed pilot clinical trial update for the Lung Transplant READY study in cystic fibrosis patients; results posted in December 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Clearance of 25-hydroxyvitamin D in Cystic Fibrosis [Phase 1]
Phase 1 clinical trial updating clearance of 25-hydroxyvitamin D in individuals with cystic fibrosis; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: A Study to Evaluate ELX/TEZ/IVA on Cough and Physical Activity in Participants With Cystic Fibrosis (CF) [Phase 3]
Phase 3 trial results for Trikafta (elexacaftor/tezacaftor/ivacaftor) evaluating cough and physical activity in cystic fibrosis have been co…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis [Phase 4]
Phase 4 trial comparing US-marketed Creon from a modernized process at an alternate site and with the approved process at a different site i…
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Ceftolozane/Tazobactam Continuous Infusion for Infective Exacerbations of Cystic Fibrosis and Bronchiectasis [Phase 4]
Phase 4 clinical trial update for continuous infusion ceftolozane/tazobactam in infective exacerbations of cystic fibrosis and bronchiectasi…
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are Less Than 24 Months of Age and Have an Ivacaftor-Responsive CFTR Mutation [Phase 3]
Phase 3 trial evaluating safety, pharmacokinetics, and pharmacodynamics of ivacaftor in cystic fibrosis patients under 24 months with Ivacaf…
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD in Cystic Fibrosis Patients With at Least 1 G542X Allele [Phase 2]
A Phase 2 clinical trial update evaluating safety, tolerability, PK and PD in cystic fibrosis patients with at least one G542X allele has be…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: A Study to Assess the Effect of ELX/TEZ/IVA on Glucose Tolerance in Participants With Cystic Fibrosis (CF) [Phase 3]
Phase 3 trial assessing the effect of ELX/TEZ/IVA on glucose tolerance in participants with cystic fibrosis has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2023-07-28Clinical Trial Update: A Study Evaluating the Long-Term Safety of Elexacaftor Combination Therapy [Phase 3]
Phase 3 study evaluating long-term safety of elexacaftor combination therapy in cystic fibrosis has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: A Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor in Participants With Cystic Fibrosis (CF) [Phase 3]
A Phase 3 study evaluating the safety of the triple combination elexacaftor/tezacaftor/ivacaftor in participants with cystic fibrosis has co…
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: A Study Evaluating the Long-term Safety of VX-445 Combination Therapy [Phase 3]
A Phase 3 study assessing the long-term safety of VX-445 combination therapy in cystic fibrosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years [Phase 3]
Phase 3 trial evaluating ELX/TEZ/IVA in children aged 2 through 5 years with cystic fibrosis has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222 [Phase 2]
Phase 2 study of ABBV-3067 alone and with ABBV-2222 in cystic fibrosis completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Cystic Fibrosis - Insulin Deficiency, Early Action [Phase 3]
Phase 3 clinical trial update for cystic fibrosis exploring early insulin deficiency action; study completed.
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: ATCF (Azole Therapy in Cystic Fibrosis) [Phase 2]
Phase 2 clinical trial of azole therapy in cystic fibrosis patients with Aspergillus infections has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: Gut Imaging for Function & Transit in Cystic Fibrosis Study 2 [Phase 2]
Phase 2 clinical trial evaluating gut imaging for function and transit in cystic fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-22Clinical Trial Update: Pilocarpine Microneedles for Sweat Induction (PMN-SI) [NA]
Completed clinical trial evaluating pilocarpine microneedles for sweat induction in cystic fibrosis patients; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis [Phase 2]
Phase 2 trial evaluating VX-121 combination therapy for cystic fibrosis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects [Phase 1, Phase 2]
Phase 1 and Phase 2 clinical trial update for inhaled AR-501 in healthy adults and Pseudomonas aeruginosa-infected cystic fibrosis subjects;…